Biospecifics Technologies (BSTC) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts BSTC Hot Sheet
Price: $88.53 --0%
Financial Fact:
Income (loss) before expense for income tax: 4.81M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income (loss) before expense for income tax: 4.81M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Biospecifics Technologies (NASDAQ: BSTC) reported Q3 EPS of $0.21, $0.02 better than the analyst estimate of $0.19. Revenue for the quarter came in at $4 million versus the consensus estimate of $4 million.
For earnings history and earnings-related data on Biospecifics Technologies (BSTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
- Omega Flex (OFLX) Tops Q2 EPS by 27c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
